Edwards Lifesciences

Edwards Lifesciences is a publicly traded American medical-device company specializing in cardiovascular technologies, particularly transcatheter heart valves and hemodynamic monitoring systems. It trades on the NYSE under the ticker EW, and is headquartered in Irvine, California.

The company's primary product line is transcatheter aortic valve replacement (TAVR) under the SAPIEN brand, designed for patients with severe aortic stenosis who are not candidates for open-heart surgery. Edwards also produces hemodynamic monitoring platforms including ClearSight and EV1000. Its customers are hospitals, interventional cardiologists, and cardiac surgeons.

Detailed public information about a dedicated R&D center or significant local engineering presence for Edwards Lifesciences in Israel is limited and not something I can confirm with confidence.